Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Commentary

Commentary on “The Role of Mitochondria in Systemic Lupus Erythematosus: A Glimpse of Various Pathogenetic Mechanisms” by Prof. Yang et al., Department of Nephrology and Rheumatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China, Curr. Med. Chem., 2020, 27(20), 3346-3361.

Author(s): Qingjun Pan, Yanse Chen, Shujun Wang, Yong-Zhi Xu* and Hua-Feng Liu*

Volume 28, Issue 10, 2021

Published on: 16 April, 2021

Page: [2077 - 2079] Pages: 3

DOI: 10.2174/092986732810210416082734

« Previous
[1]
Arroyo, J.D.; Jourdain, A.A.; Calvo, S.E.; Ballarano, C.A.; Doench, J.G.; Root, D.E.; Mootha, V.K. A genome-wide CRISPR death screen identifies genes essential for oxidative phosphorylation. Cell Metab., 2016, 24(6), 875-885.
[http://dx.doi.org/10.1016/j.cmet.2016.08.017] [PMID: 27667664]
[2]
Faccio, A.T.; Ruperez, F.J.; Singh, N.S.; Angulo, S.; Tavares, M.; Bernier, M.; Barbas, C.; Wainer, I.W. Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells. Biochim. Biophys. Acta Gen., 2018, 1862(6), 1505-1515.
[http://dx.doi.org/10.1016/j.bbagen.2018.03.008] [PMID: 29526507]
[3]
Giorgi, C.; Marchi, S.; Pinton, P. The machineries, regulation and cellular functions of mitochondrial calcium. Nat. Rev. Mol. Cell Biol., 2018, 19(11), 713-730.
[http://dx.doi.org/10.1038/s41580-018-0052-8] [PMID: 30143745]
[4]
Bogner, C.; Leber, B.; Andrews, D.W. Apoptosis: embedded in membranes. Curr. Opin. Cell Biol., 2010, 22(6), 845-851.
[http://dx.doi.org/10.1016/j.ceb.2010.08.002] [PMID: 20801011]
[5]
Pisetsky, D.S. The role of mitochondria in immune-mediated disease: the dangers of a split personality. Arthritis Res. Ther., 2016, 18, 169.
[http://dx.doi.org/10.1186/s13075-016-1063-5] [PMID: 27424174]
[6]
Lee, H.-T.; Wu, T.-H.; Lin, C.-S.; Lee, C.-S.; Wei, Y.-H.; Tsai, C.-Y.; Chang, D.-M. The pathogenesis of systemic lupus erythematosus - from the viewpoint of oxidative stress and mitochondrial dysfunction. Mitochondrion, 2016, 30, 1-7.
[http://dx.doi.org/10.1016/j.mito.2016.05.007] [PMID: 27235747]
[7]
Tsokos, G.C. Systemic lupus erythematosus. N. Engl. J. Med., 2011, 365(22), 2110-2121.
[http://dx.doi.org/10.1056/nejmra1100359] [PMID: 22129255]
[8]
Liu, Z.; Davidson, A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat. Med., 2012, 18(6), 871-882.
[http://dx.doi.org/10.1038/nm.2752] [PMID: 22674006]
[9]
Pan, Q.; Gao, C.; Chen, Y.; Feng, Y.; Liu, W.J.; Liu, H.-F. Update on the role of autophagy in systemic lupus erythematosus: a novel therapeutic target. Biomed. Pharmacother., 2015, 71, 190-193.
[http://dx.doi.org/10.1016/j.biopha.2015.02.017] [PMID: 25960235]
[10]
Yang, S.-K.; Zhang, H.-R.; Shi, S.-P.; Zhu, Y.-Q.; Song, N.; Dai, Q.; Zhang, W.; Gui, M.; Zhang, H.; Yang, S.K.; Zhang, H.R.; Shi, S.P.; Zhu, Y.Q.; Song, N.; Dai, Q.; Zhang, W.; Gui, M.; Zhang, H. The role of mitochondria in systemic lupus erythematosus: a glimpse of various pathogenetic mechanisms. Curr. Med. Chem., 2020, 27(20), 3346-3361.
[http://dx.doi.org/10.2174/0929867326666181126165139] [PMID: 30479205]
[11]
Koutsokeras, T.; Healy, T. Systemic lupus erythematosus and lupus nephritis. Nat. Rev. Drug Discov., 2014, 13(3), 173-174.
[http://dx.doi.org/10.1038/nrd4227] [PMID: 24525782]
[12]
Yang, C.; Xue, J.; An, N.; Huang, X.-J.; Wu, Z.-H.; Ye, L.; Li, Z.-H.; Wang, S.-J.; Pan, Q.-J.; Liang, D.; Liu, H.-F. Accelerated glomerular cell senescence in experimental lupus nephritis. Med. Sci. Monit., 2018, 24, 6882-6891.
[http://dx.doi.org/10.12659/msm.909353] [PMID: 30265659]
[13]
Chun, J.; Chung, H.; Wang, X.; Barry, R.; Taheri, Z.M.; Platnich, J.M.; Ahmed, S.B.; Trpkov, K.; Hemmelgarn, B.; Benediktsson, H.; James, M.T.; Muruve, D.A. NLRP3 localizes to the tubular epithelium in human kidney and correlates with outcome in IgA nephropathy. Sci. Rep., 2016, 6, 24667.
[http://dx.doi.org/10.1038/srep24667] [PMID: 27093923]
[14]
Liu, D.; Xu, M.; Ding, L.-H.; Lv, L.-L.; Liu, H.; Ma, K.-L.; Zhang, A.-H.; Crowley, S.D.; Liu, B.-C. Activation of the NLRP3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation. Int. J. Biochem. Cell Biol., 2014, 57, 7-19.
[http://dx.doi.org/10.1016/j.biocel.2014.09.018] [PMID: 25281528]
[15]
Chang, Y.-P.; Ka, S.-M.; Hsu, W.-H.; Chen, A.; Chao, L.K.; Lin, C.-C.; Hsieh, C.-C.; Chen, M.-C.; Chiu, H.-W.; Ho, C.L.; Chiu, Y.-C.; Liu, M.-L.; Hua, K.-F. Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy. J. Cell. Physiol., 2015, 230(7), 1567-1579.
[http://dx.doi.org/10.1002/jcp.24903] [PMID: 25535911]
[16]
Tsai, Y.-L.; Hua, K.-F.; Chen, A.; Wei, C.-W.; Chen, W.-S.; Wu, C.-Y.; Chu, C.-L.; Yu, Y.-L.; Lo, C.-W.; Ka, S.-M. NLRP3 inflammasome: pathogenic role and potential therapeutic target for IgA nephropathy. Sci. Rep., 2017, 7(1), 41123.
[http://dx.doi.org/10.1038/srep41123] [PMID: 28117341]
[17]
Kawai, Y.; Masutani, K.; Torisu, K.; Katafuchi, R.; Tanaka, S.; Tsuchimoto, A.; Mitsuiki, K.; Tsuruya, K.; Kitazono, T. Association between serum albumin level and incidence of end-stage renal disease in patients with immunoglobulin A nephropathy: a possible role of albumin as an antioxidant agent. PLoS One, 2018, 13(5), e0196655.
[http://dx.doi.org/10.1371/journal.pone.0196655] [PMID: 29795559]
[18]
Nishida, M.; Morimoto, M.; Ohno, K.; Hamaoka, K. IgA nephropathy in a girl with mitochondrial disease. Pediatr. Int., 2015, 57(2), e50-e52.
[http://dx.doi.org/10.1111/ped.12540] [PMID: 25661793]
[19]
Wen, S.; Niedzwiecka, K.; Zhao, W.; Xu, S.; Liang, S.; Zhu, X.; Xie, H.; Tribouillard-Tanvier, D.; Giraud, M.-F.; Zeng, C.; Dautant, A.; Kucharczyk, R.; Liu, Z.; di Rago, J.-P.; Chen, H. Identification of G8969>A in mitochondrial ATP6 gene that severely compromises ATP synthase function in a patient with IgA nephropathy. Sci. Rep., 2016, 6, 36313.
[http://dx.doi.org/10.1038/srep36313] [PMID: 27812026]
[20]
Murphy, M.P.; Hartley, R.C. Mitochondria as a therapeutic target for common pathologies. Nat. Rev. Drug Discov., 2018, 17(12), 865-886.
[http://dx.doi.org/10.1038/nrd.2018.174] [PMID: 30393373]
[21]
Shah, R.; Ramakrishnan, M.; Vollmar, A.; Harrell, A.; Van Trump, R.; Masoud, A. Henoch-Schonlein purpura presenting as severe gastrointestinal and renal involvement with mixed outcomes in an adult patient. Cureus, 2017, 9(3), e1088.
[http://dx.doi.org/10.7759/cureus.1088] [PMID: 28405538]

© 2024 Bentham Science Publishers | Privacy Policy